Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BAUSCH & LOMB STREAMLINING EFFORT INCLUDES JOB CUTS OF 1,500

This article was originally published in The Gray Sheet

Executive Summary

BAUSCH & LOMB STREAMLINING EFFORT INCLUDES JOB CUTS OF 1,500 employees, two-thirds of whom are in the firm's contact lens and sunglass businesses. The remaining cuts will come from B&L's other product areas, which include ophthalmic pharmaceuticals, OTC drugs, dental implants, skin care products, and sports optics. Representing about 10% of B&L's worldwide workforce of 15,900 employees as of January, the reduction in employment started earlier this year and is expected to be nearly completed by the end of the third quarter.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel